ARTELO BIOSCIENCES, INC. Accumulated Other Comprehensive Income
ARTELO BIOSCIENCES, INC. (ARTL) had Accumulated Other Comprehensive Income of -$242.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-12
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$242.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$246.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$272.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$277.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2026-06-30 | -$242.00K 10-Q · filed 2026-08-12 | |
| 2026-03-31 | -$246.00K 10-Q · filed 2026-05-14 | |
| 2025-12-31 | -$272.00K 10-Q · filed 2026-08-12 | |
| 2025-09-30 | -$277.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | -$295.00K 10-Q · filed 2025-08-13 | |
| 2025-03-31 | -$227.00K 8-K · filed 2025-07-11 | |
| 2024-12-31 | -$202.00K 8-K · filed 2026-03-17 | |
| 2024-09-30 | -$218.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | -$203.00K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | -$203.00K 10-Q · filed 2024-05-13 | |
| 2023-12-31 | -$203.00K 8-K · filed 2025-07-11 | |
| 2023-09-30 | -$199.00K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | -$201.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | -$205.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | -$254.00K 10-K · filed 2024-03-25 | |
| 2022-09-30 | -$388.00K 10-Q · filed 2022-11-08 | |
| 2022-06-30 | -$176.00K 10-Q · filed 2022-08-09 | |
| 2022-03-31 | -$64.00K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | -$18.00K 10-K · filed 2023-03-31 | |
| 2021-11-30 | -$23.00K 10-Q · filed 2022-01-12 | |
| 2021-08-31 | $18.00K 10-K · filed 2023-03-31 | |
| 2021-05-31 | $49.38K 10-Q · filed 2021-07-12 | |
| 2021-02-28 | $47.90K 10-Q · filed 2021-04-13 | |
| 2020-11-30 | $47.53K 10-Q · filed 2021-01-14 | |
| 2020-08-31 | $64.00K 10-KT · filed 2022-03-21 | $63.76K 10-K · filed 2020-11-04 |
| 2020-05-31 | $50.50K 10-Q · filed 2020-07-13 | |
| 2020-02-29 | $15.96K 10-Q · filed 2020-04-13 | |
| 2019-11-30 | $6.54K 10-Q · filed 2020-01-14 | |
| 2019-08-31 | -$9.81K 10-K · filed 2020-11-04 | |
| 2019-05-31 | -$10.23K 10-Q · filed 2019-07-15 | |
| 2019-02-28 | -$11.00K 10-Q · filed 2019-04-15 | |
| 2018-11-30 | -$7.39K 10-Q · filed 2019-01-14 | |
| 2018-08-31 | -$12.28K 10-K/A · filed 2019-12-18 | |
| 2018-05-31 | -$11.68K 10-Q · filed 2018-07-13 | |
| 2018-02-28 | -$1.62K 10-Q/A · filed 2018-05-14 | |
| 2017-11-30 | -$368.00 10-Q/A · filed 2018-03-21 | |
| 2017-08-31 | $657.00 10-K · filed 2018-11-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |